Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
Meer behandelopties, flexibeler inzetbaar en uniformer gemonitord
mrt 2024 | Multipele Sclerose, Stamceltransplantatie, Vaccinatie